During the 8th Microbiome Movement – Drug Development Summit, held in London at the end of January, MicrobiomePost discussed with Tim Sharpington – Chief Executive Officer, Microbiotica, about how the microbiome field should navigate through a difficult financing horizon.
Strategise how to best approach investors on the research of microbiome: a panel discussion
Tim Sharpington, Chief Executive Officer at Microbiotica, talked about how the microbiome field should navigate through a difficult financing horizon.
Latest related content
